Equities

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)84.92
  • Today's Change-0.47 / -0.55%
  • Shares traded1.27k
  • 1 Year change+22.15%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 21:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. The Company provides integrated solutions, services, and data analytics. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. The segment also includes the clinical artificial intelligence (AI) software business. Its PCS segment portfolio consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment consists of two business lines: contrast media and molecular imaging.

  • Revenue in USD (TTM)19.56bn
  • Net income in USD1.68bn
  • Incorporated2022
  • Employees51.00k
  • Location
    GE Healthcare Technologies Inc500 West Monroe StreetCHICAGO 60661United StatesUSA
  • Phone+1 (203) 360-4369
  • Fax+1 (302) 655-5049
  • Websitehttps://www.gehealthcare.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
GEHC:NSQ since
announced
Transaction
value
MIM Software IncDeal completed08 Jan 202408 Jan 2024Deal completed10.83%--
Data delayed at least 15 minutes, as of Nov 12 2024 21:15 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cooper Companies Inc3.80bn359.30m20.31bn15.00k56.802.5627.605.341.801.8019.0239.800.31961.705.56253,606.703.0210.063.2911.3466.3665.549.4529.001.185.460.24930.34698.617.24-23.74-3.6615.180.00
Zimmer Biomet Holdings Inc7.60bn1.08bn21.89bn18.00k20.941.7710.632.885.255.2536.8762.000.35380.91365.38421,972.205.052.215.822.5271.7871.2514.287.280.69877.520.342538.906.55-1.40252.86--9.440.00
Steris PLC5.12bn602.62m21.96bn18.18k36.663.3319.834.296.084.3851.6266.800.47583.865.49281,655.405.625.196.105.6843.0143.6411.8110.971.558.290.252836.5613.2813.06-1.0712.6713.698.83
Waters Corp2.91bn622.64m22.91bn7.90k36.8114.2928.127.8810.4810.4848.8927.000.6452.204.47367,740.1013.8219.7716.7225.2959.7358.4521.4323.381.3810.110.53250.00-0.52294.09-9.261.534.72--
Illumina Inc4.39bn-1.58bn23.41bn10.59k--11.05--5.33-10.00-10.0027.6113.360.54412.666.17414,542.00-19.63-6.20-23.16-7.2863.9466.39-36.08-15.481.8538.440.4834---1.756.2173.64---7.91--
West Pharmaceutical Services Inc.2.88bn499.60m23.73bn10.60k48.558.6337.428.256.756.7538.8637.960.77434.505.51271,358.5013.0215.6115.1618.6534.8738.0616.8118.472.23--0.069510.692.1811.432.2823.7628.166.20
DexCom Inc3.95bn680.80m29.04bn9.60k45.3814.6732.517.341.641.649.525.070.61072.764.42411,875.0010.518.3014.2810.5062.1065.9017.2214.142.12--0.55790.0024.4928.5658.70--28.66--
IDEXX Laboratories, Inc.3.84bn866.24m34.89bn11.00k41.1121.6035.179.0810.3610.3646.0019.721.193.857.14349,528.8026.9128.0038.8643.4960.7258.7422.5321.351.0359.100.35070.008.7210.5924.4417.391.68--
Resmed Inc4.81bn1.11bn36.29bn9.98k32.776.9828.147.557.547.5432.5935.390.68862.176.08481,711.9015.9414.2418.1116.5357.6756.8523.1520.351.9144.710.115432.6210.9512.4413.7519.988.235.34
Veeva Systems Inc2.57bn615.26m38.30bn7.17k61.377.3858.7614.883.853.8515.6932.040.4453--6.27358,846.8010.6511.9712.9715.3673.3572.0023.9123.74----0.000.009.6822.357.7918.0021.68--
Agilent Technologies Inc6.50bn1.41bn38.41bn17.40k27.806.5123.105.914.814.8122.1420.530.59962.875.06358,950.3013.0411.0016.1313.2554.7553.2921.7518.011.3755.860.331921.46-0.2196.82-1.127.3910.988.86
GE HealthCare Technologies Inc19.56bn1.68bn38.80bn51.00k23.264.6616.771.983.653.6542.6318.200.59065.404.41383,490.205.22--6.97--41.33--8.84--0.9825.670.5478--6.60---26.82------
Edwards Lifesciences Corp5.62bn1.43bn38.81bn19.80k27.794.0724.856.902.376.939.3216.180.50321.127.72283,904.0012.7616.6314.9819.1278.6376.7125.3524.842.89--0.05850.0011.5610.03-7.8513.701.96--
Cencora Inc293.96bn1.51bn49.02bn42.00k33.1562.3118.600.16687.517.511,467.703.994.5315.5912.44--2.341.1211.514.833.353.250.51680.25560.529119.370.84865.3812.1210.36-13.5313.029.454.98
Data as of Nov 12 2024. Currency figures normalised to GE Healthcare Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

43.01%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (Global Investors)as of 30 Jun 202454.15m11.86%
The Vanguard Group, Inc.as of 30 Jun 202447.14m10.32%
BlackRock Fund Advisorsas of 30 Jun 202423.59m5.17%
SSgA Funds Management, Inc.as of 30 Jun 202417.27m3.78%
Dodge & Coxas of 30 Jun 202416.71m3.66%
Geode Capital Management LLCas of 30 Jun 202410.24m2.24%
T. Rowe Price Investment Management, Inc.as of 30 Jun 20248.07m1.77%
AllianceBernstein LPas of 30 Jun 20246.84m1.50%
T. Rowe Price Associates, Inc. (IM)as of 30 Jun 20246.74m1.48%
Egerton Capital (UK) LLPas of 30 Sep 20245.68m1.24%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.